www.午夜视频_亚洲人在线播放_看一级黄色大片_免费高清av_国产成人精品国内自产拍免费看_日韩av一区二区三区在线观看

加入收藏 | 設為首頁 | 聯系我們

產品搜索

聯系我們

聯系人：蔣經理
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區緯地路9號
Email： zhangxiangwen@cobioer.com

產品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73192SLC34A2-ROS1 G2032R/BaF3

SLC34A2-ROS1 G2032R/BaF3
名稱 SLC34A2-ROS1 G2032R/BaF3
型號 CBP73192
報價
特點 SLC34A2-ROS1 [G2032R]/BaF3,母細胞：BaF3，凍存條件：90% FBS+10% DMSO
  • 詳細內容
CBP73192
I. Introduction

Cell Line Name：

SLC34A2-ROS1 [G2032R]/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative


II.Background

Approximately 2% of lung tumors harbor ROS1 fusions (Bergethon et al. 2012). Like ALK fusions, ROS1 fusions are more commonly found in light smokers (<10 pack years) and/or never-smokers. ROS1 fusions are also associated with younger age and adenocarcinomas (Bergethon et al. 2012).

In preclinical models, ROS1 fusions are associated with sensitivity to tyrosine kinase inhibitors that have 'off-target' activity against ROS1, such as crizotinib (Bergethon et al. 2012; Davies et al. 2012). In addition, two patients—a previously treated metastatic NSCLC patient and a 65-year-old never smoker NSCLC patient—with tumors harboring ROS1 fusions have had partial responses to crizotinib (Bergethon et al. 2012; Davies et al. 2012). In an expansion cohort of a phase I study, 50 patients with ROS1-positive NSCLC demonstrated a 72% response rate and 19.2-month median progression-free survival interval when treated with crizotinib (Ou et al. 2013; Shaw et al. 2014). In a European case study, 32 ROS1-positive NSCLC cases treated with crizotinib were retrospectively reviewed, and an 80% response rate and a 9.1-month median progression-free survival interval was calculated in this cohort (Mazières et al. 2015).

Several different ROS1 rearrangements have been described in NSCLC. These include SLC34A2-ROS1, CD74-ROS1, EZR-ROS1, TPM3-ROS1, and SDC4-ROS1 (Figure 1; Davies et al. 2012; Rikova et al. 2007; Takeuchi et al. 2012). Clinically, the presence of a ROS1 rearrangement is detected by fluorescence in situ hybridization (FISH) with a ROS1 breakapart probe. FISH testing is not able to discern which particular ROS1 fusion is found in a clinical sample.

ROS1 rearrangements are non-overlapping with other oncogenic mutations found in NSCLC (e.g., EGFR mutations, KRAS mutations, ALK fusions, etc.; Bergethon et al. 2012).


III. Representative Data

1. WB of SLC34A2-ROS1 [G2032R]/BaF3expression

CBP73192 WB.png


Figure 1. Protein Expression of ROS1 detected by antibody


2.Sanger Sequencing of SLC34A2-ROS1 Fusion and G2032R mutation

CBP73192 sanger-1.png

Figure 2. SLC34A2-ROS1 Fusion

CBP73192 sanger2.png

Figure 3. ROS1 p.G2032R


3. Anti-proliferation assay

CBP73192 fig.png

Figure 4. Anti-proliferation assay of two reference compounds on the SLC34A2-ROS1 [G2032R]/BaF3 Stable Cell Line.



如果你對CBP73192SLC34A2-ROS1 G2032R/BaF3感興趣，想了解更詳細的產品信息，填寫下表直接與廠家聯系：


留言框

  • 產品：

  • 您的單位：

  • 您的姓名：

  • 聯系電話：

  • 常用郵箱：

  • 省份：

  • 詳細地址：

  • 補充說明：

  • 驗證碼：

    請輸入計算結果（填寫阿拉伯數字），如：三加四=7

化工儀器網

推薦收藏該企業網站
主站蜘蛛池模板： 五月天国产在线 | 手机在线不卡av | 一区二区三区av | 免费成人高清在线视频 | 久久99久久99精品免视看婷婷 | 伊人久麻豆社区 | 成人免费淫片aa视频免费 | 中文字幕视频一区二区 | 国产农村妇女精品一二区 | 日韩电影中文字幕 | 成人免费福利视频 | 91在线电影| 国产精品久久久爽爽爽麻豆色哟哟 | 中文字幕乱码一区二区三区 | 国产在线网址 | 日韩免费视频一区二区 | 国产一区免费视频 | 欧美日韩电影一区二区 | 伊人久久综合 | 亚洲激情在线视频 | 激情在线视频 | 国产午夜精品一区二区三区四区 | 免费观看一区二区三区毛片 | 日韩欧美一区二区三区免费观看 | 久久看看| 国产视频久久 | 最新日韩av | 成人综合一区 | 九九热在线精品视频 | 久久51 | 国产日韩欧美 | 欧美αv| 欧美乱操 | 国产欧美一区二区三区久久人妖 | 羞羞的视频网站 | 999精品在线 | 久久99精品久久久久婷婷 | 国产99精品 | 黄在线免费观看 | 亚洲精品av在线 | 在线免费观看黄a |